Comments
Loading...
Tempest Therapeutics (NASDAQ:TPST) Stock, Earnings Estimates, EPS, And Revenue
Tempest Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 18
EPS Estimate
$-0.250
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Tempest Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Tempest Therapeutics (TPST) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.41 | $-0.35 | -17.1 % |
| Q2 | 2024-08-08 | $-0.42 | $-0.40 | -5.00 % |
| Q1 | 2024-05-09 | $-0.36 | $-0.39 | 7.69 % |
| Q4 | 2024-03-19 | $-0.34 | $-0.39 | 12.8 % |
Tempest Therapeutics (TPST) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Tempest Therapeutics (NASDAQ:TPST) reporting earnings?
Tempest Therapeutics (TPST) is scheduled to report earnings on March 18, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Tempest Therapeutics (NASDAQ:TPST)?
The Actual EPS was $-0.41, which missed the estimate of $-0.35.
What were Tempest Therapeutics’s (NASDAQ:TPST) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.